---
title: Trevo 3 Mm and/or AXS Catalyst 5 for the Treatment of Medium Distal Vessel
  Occlusion Stroke-results from the ASSIST Registry
date: '2024-08-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39179880/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240824182422&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: The data suggests that the Trevo 3 mm SR and/or the AXS
  Catalyst 5 may be an option to treat medium distal vessel occlusion, but more data
  is needed to demonstrate safety and efficacy in this patient cohort. Further improvements
  are needed regarding materials and techniques to improve reperfusion results in
  this patient cohort in the ...'
disable_comments: true
---
CONCLUSION: The data suggests that the Trevo 3 mm SR and/or the AXS Catalyst 5 may be an option to treat medium distal vessel occlusion, but more data is needed to demonstrate safety and efficacy in this patient cohort. Further improvements are needed regarding materials and techniques to improve reperfusion results in this patient cohort in the ...